Page last updated: 2024-08-24

valsartan and Atrial Remodeling

valsartan has been researched along with Atrial Remodeling in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Deng, CY; Deng, H; Fang, Y; Kuang, SJ; Li, LA; Li, Q; Li, QQ; Liu, Y; Peng, DW; Rao, F; Wei, W; Wu, SL; Xue, YM; Yang, H; Zeng, P; Zhang, MZ; Zhang, QH1
Deng, CY; Guo, HM; Li, X; Liu, FZ; Liu, Y; Rao, F; Wang, ZY; Wei, W; Wu, SL; Xue, YM; Yang, H; Zhang, MZ1
Chen, Q; Li, D; Lu, C; Wang, Y; Xu, T; Zhou, R1
Chang, JP; Chang, TH; Chen, MC; Ho, WC; Hsiao, CC; Hsu, SD; Huang, HD; Liu, WH; Wang, FS1
Chen, JH; Chen, LL; Chen, XH; Fu, FY; Tang, MR; Wang, WW; Zhang, FL1

Reviews

1 review(s) available for valsartan and Atrial Remodeling

ArticleYear
Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis.
    Journal of the American Heart Association, 2019, 07-02, Volume: 8, Issue:13

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Remodeling; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Ventricular Remodeling; Walk Test

2019

Other Studies

4 other study(ies) available for valsartan and Atrial Remodeling

ArticleYear
Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
    European journal of pharmacology, 2023, Aug-05, Volume: 952

    Topics: Aminobutyrates; Angiotensins; Animals; Antihypertensive Agents; Atrial Fibrillation; Atrial Remodeling; Biphenyl Compounds; Drug Combinations; Hypertension; Neprilysin; Rats; Rats, Inbred SHR; Tetrazoles; Valsartan

2023
High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
    Journal of molecular and cellular cardiology, 2020, Volume: 140

    Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Hydrostatic Pressure; Mice; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; src-Family Kinases; Up-Regulation; Valsartan

2020
Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
    Translational research : the journal of laboratory and clinical medicine, 2015, Volume: 165, Issue:5

    Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Remodeling; Down-Regulation; Female; Gene Expression Profiling; Heart Atria; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Renin-Angiotensin System; Swine; Swine, Miniature; Tetrazoles; Translational Research, Biomedical; Up-Regulation; Valine; Valsartan

2015
Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Canadian journal of physiology and pharmacology, 2015, Volume: 93, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Apoptosis; Arrhythmias, Cardiac; Atrial Remodeling; Benzimidazoles; Benzoates; Blood Pressure; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Heart Rate; Hypertension; Male; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; ras Proteins; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Telmisartan; Time Factors; Valsartan

2015